New incident report
Incident Report Number: 2008-1024
Registrant Reference Number: 269763
Registrant Name (Full Legal Name no abbreviations): Bell Laboratories, Inc.
Address: 3699 Kinsman Blvd
City: Madison
Prov / State: WI
Country: USA
Postal Code: 53704
Domestic Animal
Country: UNITED STATES
Prov / State: ILLINOIS
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: TOMCAT Vitamin D3 Mouse Poison
Bait
Yes
Unknown
Site: Res. - In Home / Rés. - à l'int. maison
Animal's Owner
Dog / Chien
Toy Poodle
1
Female
1.25
10.00
lbs
Oral
<=15 min / <=15 min
>2 hrs <=8 hrs / > 2 h < = 8 h
System
Persisted until death
Yes
Yes
1
Day(s) / Jour(s)
Died
Accidental ingestion/Ingestion accident.
(eg. description of the frequency and severity of the symptoms
12/11/2007 7:57:02 PMThe caller's dog ingested entire tray of product on 12/11/07 and developed diarrhea 12 hours later. On 12/12/07 the dog was evaluated by a veterinarian and found to have elevated calcium and phosphorus levels (calcium at 15.9, phosphorus at 7.5). All other lab values were within normal limits. At that point the dog was admitted to the hospital. It was recommended that the dog be started on intravenous fluids, prednisone, furosemide and pamidronate. The veterinarian was advised to hospitalize the dog for multiple days. According the owner, the dog was released the following day because her lab values ¿¿¿looked good¿¿? and she had improved clinically. Approximately three days post discharge, the dog slowly started to decline and began refusing food and water. The owners were not able to afford further veterinary care and the dog died at home one week post ingestion.
Death
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.